The global Digital Pathology Market was valued at $395.64Million in 2017 and is forecast to grow at a modest 13.4 % CAGR between 2018 and 2025, culminating in 2025 global sales of $ 923.64Million.
Digital pathology is a process of getting images from a digital glass slide and interpretation of acquired information. Its application includes primary diagnosis, diagnostic consultation, intraoperative diagnosis, medical student and resident training, manual and semi-quantitative review of immunohistochemistry (IHC), clinical research, diagnostic decision support, peer review, and tumor boards.
IN March 2017, Philips and LabPON enter into an agreement to create a digital database of massive aggregated sets of annotated pathology images and big data utilizing Philips IntelliSite Pathology Solution. LabPON transition to 100% histopathology digital diagnosis.
We can capture the entire glass slide under brightfield or fluorescent conditions at a magnification as in microscope using high-throughput automated digital pathology scanner.These digital slides can be shared within physician network through specialized digital pathology software applications.
In 2017, North America was the leading region by revenue owing to factors such as the presence of well-developed hospital and diagnostic center network, the high rate of diagnosis, transparent process for availing reimbursement, and high emphasis on research & development.
There is different type of digital pathology technology such as:
- Whole Slide Imaging
The key market participants include 3DHistech Inc, Leica Biosystems, Definiens, Olympus Corporation, GE Healthcare, Omynx LLC, Philips Healthcare, MicroSkan Technologies, Objective Pathology Services, LigoLAb LLC, Hamamatsu Photonics Inc. and Ventana Medical Systems Inc.
———>>> In-depth Analysis Report On Digital Pathology Market by Ameri Research Inc.
Digital Pathology Market Outlook To 2025: Key Technology Categories (Whole Slide Imaging, Telepathology), Application (Academic Research, Diagnosis, Drug Discovery), End-Use (Hospital, Clinics, Diagnostic Labs and Research Centers), Regional Segmentation, Competitive Dynamics, M&A Insights, Pricing Analysis (OPP, IPP, RAP), And Segment Forecast